You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

20-115

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Idiopathic Pulmonary Fibrosis Trial in Hialeah Gardens (20mM sodium pyruvate nasal spray, Saline Placebo control nasal spray)

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • 20mM sodium pyruvate nasal spray
  • Saline Placebo control nasal spray
  • Hialeah Gardens, Florida
    Family First Medical Research Center
Sep 16, 2023

Macrolane Prospective Survey

Withdrawn
  • Females Recently Treated With Macrolane VRF in the Breasts
    • Stockholm, Sweden
      Akademikliniken
    Aug 24, 2022

    Melanoma Trial in Worldwide (relatlimab+nivolumab, relatlimab+nivolumab+rHuPH20, nivolumab)

    Not yet recruiting
    • Melanoma
    • Anchorage, Alaska
    • +28 more
    Oct 20, 2023

    A Study of Brentuximab Vedotin in Adults With Hodgkin's Lymphoma

    Recruiting
    • Hodgkin Lymphoma
    • No Intervention
    • Wroclaw, Dolnoslskie, Poland
    • +14 more
    Jun 23, 2022

    COVID-19 Trial in Worldwide (ADG20, Normal saline)

    Terminated
    • COVID-19
    • Estomba, Buenos Aires, Argentina
    • +67 more
    Nov 22, 2022

    Sickle Cell Disease (SCD) Trial in Worldwide (Crizanlizuamb, Standard of Care)

    Active, not recruiting
    • Sickle Cell Disease (SCD)
    • Birmingham, Alabama
    • +24 more
    Jan 12, 2023

    Multiple Myeloma, Lymphoma, Amyloidosis Trial in Worldwide (Ixazomib)

    Active, not recruiting
    • Multiple Myeloma
    • +2 more
    • Atlanta, Georgia
    • +23 more
    Dec 20, 2021

    Acromegaly Trial in Worldwide (CAM2029 (octreotide subcutaneous depot), Matching )

    Active, not recruiting
    • Acromegaly
    • CAM2029 (octreotide subcutaneous depot)
    • Matching placebo
    • Los Angeles, California
    • +62 more
    Dec 9, 2022

    Lupus Erythematosus, Systemic Trial in Worldwide (BIIB059, BIIB059 matching )

    Recruiting
    • Lupus Erythematosus, Systemic
    • Upland, California
    • +41 more
    Apr 19, 2022

    Neuroblastoma, Solid Tumor Trial (APG-115, APG-2575)

    Not yet recruiting
    • Neuroblastoma
    • Solid Tumor
    • (no location specified)
    Jan 18, 2023

    COVID-19 Trial in Worldwide (AT-527, Placebo)

    Completed
    • COVID-19
    • Blagoevgrad, Bulgaria
    • +42 more
    Nov 1, 2021

    Tumor, Metastatic Melanoma, Melanoma Trial in Houston (OBX-115, Acetazolamide, Cyclophosphamide)

    Not yet recruiting
    • Tumor
    • +2 more
    • Houston, Texas
      MD Anderson Cancer Center
    Aug 16, 2022

    Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (efgartigimod PH20 SC, prednisone)

    Recruiting
    • Pemphigus Vulgaris
    • Pemphigus Foliaceus
    • Birmingham, Alabama
    • +120 more
    Dec 22, 2022

    Melanoma Trial in Worldwide (Ceralasertib, Durvalumab)

    Recruiting
    • Melanoma
    • Los Angeles, California
    • +75 more
    Dec 5, 2022

    Refractory or Recurrent Solid Tumors, Rhabdomyosarcoma, Non-Rhabdomyosarcoma Soft Tissue Sarcoma Trial in Worldwide (Eribulin

    Completed
    Has Results
    • Refractory or Recurrent Solid Tumors
    • +3 more
    • Eribulin mesilate
    • Irinotecan hydrochloride
    • Marseille, Bouches-du-Rhône, France
    • +38 more
    Jun 20, 2022

    Pemphigus Vulgaris, Pemphigus Foliaceus Trial in Worldwide (biological, other, drug)

    Recruiting
    • Pemphigus Vulgaris
    • Pemphigus Foliaceus
    • efgartigimod PH20 SC
    • +2 more
    • Birmingham, Alabama
    • +130 more
    Dec 22, 2022

    Alzheimer Trial in San Francisco ([18F]RP-115 PET/MRI)

    Recruiting
    • Alzheimer Disease
    • [18F]RP-115 PET/MRI
    • San Francisco, California
      China Basin, UCSF
    May 9, 2022

    Lupus Erythematosus, Systemic Trial in Worldwide (VIB7734, Placebo)

    Active, not recruiting
    • Lupus Erythematosus, Systemic
    • La Jolla, California
    • +88 more
    Jan 10, 2023

    Multiple Sclerosis Trial in Worldwide (Ponesimod)

    Active, not recruiting
    • Multiple Sclerosis
    • Carlsbad, California
    • +147 more
    Aug 16, 2022

    Melanoma Trial in Worldwide (Nivolumab 3 mg/kg IV, Ipilimumab 1 mg/kg IV, Nivolumab 1 mg/kg IV)

    Completed
    Has Results
    • Melanoma
    • Nivolumab 3 mg/kg IV
    • +4 more
    • Aurora, Colorado
    • +56 more
    Jun 17, 2022

    Chronic Spontaneous Urticaria Trial in Worldwide (Ligelizumab, Omalizumab, Placebo)

    Completed
    Has Results
    • Chronic Spontaneous Urticaria
    • Ligelizumab
    • +2 more
    • Gilbert, Arizona
    • +160 more
    Dec 12, 2022

    Hypoactive Sexual Desire Disorder (HSDD) Trial in United States (Placebo Vaginal Insert, Prasterone 6.5 mg (0.50%) Vaginal

    Withdrawn
    • Hypoactive Sexual Desire Disorder (HSDD)
    • Placebo Vaginal Insert
    • Prasterone 6.5 mg (0.50%) Vaginal Insert
    • Huntsville, Alabama
    • +9 more
    Jul 29, 2020

    Genetic Diagnosis in Congenital Cataracts

    Completed
    • Congenital Cataract
    • Ophthalmic examination
    • Whole-exome sequencing
    • Guangzhou, Guangdong, China
      Zhongshan Ophthalmic Center, Sun Yat-sen University
    Mar 12, 2023

    Malignant Melanoma Trial in Worldwide (Dabrafenib, Trametinib)

    Completed
    • Malignant Melanoma
    • Rosario, Sante Fe, Argentina
    • +99 more
    Oct 14, 2021

    Liposarcoma, Advanced Solid Tumor Trial in Guangzhou, Shanghai (APG-115, Toripalimab)

    Recruiting
    • Liposarcoma
    • Advanced Solid Tumor
    • Guangzhou, Guangdong, China
    • +1 more
    Sep 22, 2021